| Region: | |
| Category: |
(138 reports matching your criteria)
|
Big Multinational Pharma in China
1/8/2013 | published by: Datamonitor
... drivers elsewhere around the globe, particularly in emerging markets such as China. Features and benefits Outlines multinational pharma companies’ history, operations, and key deals made in China to help you create an effective market entry ...
|
read more...
|
$2,500.00
|
|
Research on China’s Animal Vaccine Industry, 2013-2017
1/7/2013 | published by: Huidian Research
... 42.3% of the total sales amount respectively. The market scale of China's animal vaccine is nearly CNY 10 billion in 2012. Although there are nearly 60 animal vaccine manufacturers in China, the market share is ...
|
read more...
|
$2,100.00
|
|
Research Report on China's Antidepressant Market, 2013-2017
12/26/2012 | published by: China Research and Intelligence Co., Ltd.
... million people commit suicide every year because of depression. Depression becomes a health crisis worldwide. Depression (also DEP) is a set of mood disorders or affective disorders with the main symptom of depression caused by ...
|
read more...
|
$2,800.00
|
|
Research Report on China's Diabetes Drug Market, 2013-2017
12/26/2012 | published by: China Research and Intelligence Co., Ltd.
... various pathogenic factors such as genetic factors, immune disorders, microbial infections and their toxins, free radical toxins, psychological factors on body. In recent years, with the development of China's economy and improvement in people's living ...
|
read more...
|
$2,800.00
|
|
Research Report on China's Antifungal Drug Market, 2013-2017
12/26/2012 | published by: China Research and Intelligence Co., Ltd.
... tend to gradually increase in China, which is related to following factors to a certain extent: (1)Patients in hospital for a long term caused by severe basic diseases or lots of combined diseases will reduce ...
|
read more...
|
$2,800.00
|
|
2013 Japan Sexually-Transmitted Diseases: Market Outlook and Emerging Opportunities
12/21/2012 | published by: Venture Planning Group
... Papillomavirus (Pap Smear, HPV), and Syphilis. The report provides test volume and sales projections for Hospitals and Commercial/Private Labs. In addition to market share and sales forecasts, the report: - Examines market applications of Molecular ...
|
read more...
|
$2,400.00
|
|
Research Report on China's Antithrombotic Drug Market, 2013-2017
12/14/2012 | published by: China Research and Intelligence Co., Ltd.
... primary reason for incidence and death of cardiovascular diseases, which is also one of the important causes for death of cancer patients. Nowadays, cardiac-cerebral thrombotic diseases (stroke and myocardial infarction) are severely threatening the life ...
|
read more...
|
$2,400.00
|
|
Rheumatoid Arthritis in Brazil, Russia, and China – How Are Payers and Prescribers Promoting or Limiting Growth in the Biologics Markets
11/30/2012 | published by: Decision Resources
... by a growing prevalent population with greater access to medical care and by rheumatologists’ increasing use of more aggressive treatments. Increased government spending on healthcare and improved penetration of biological agents make this an attractive ...
|
read more...
|
$10,000.00
|
|
Research Report on China's Hypolipidemic Drug Market, 2012-2013
11/20/2012 | published by: China Research and Intelligence Co., Ltd.
... safety of people. Therefore, the search for hypolipidemic drugs with significant efficacy, safety and reliability has been a long-term and quite popular research subject in the pharmaceutical field. According to surveys, the overall morbidity rate ...
|
read more...
|
$2,400.00
|
|
Drug Discovery and Development Market in Asia - Partnerships Between MNCs and Asian Academic Institutions and Healthcare Research Organizations are Driving R&D Innovation
11/9/2012 | published by: GBI Research
... research, “Drug Discovery and Development Market in Asia - Partnerships Between MNCs and Asian Academic Institutions and Healthcare Research Organizations are Driving R&D Innovation”. The report provides key data, information and analysis of the major ...
|
read more...
|
$3,500.00
|
|
Medical Research in China
11/7/2012 | published by: IBISWorld
... and biotech firms. The following research functions are not included in the industry: R&D activities by pharmaceutical or medical equipment manufacturing industries; research unrelated to the human body or human diseases; and the commercialization of ...
|
read more...
|
$910.00
|
|
Chinese CRO Company Report - Tigermed Consulting Co., Ltd.
11/1/2012 | published by: JZMed, Inc.
... as competent as those top tier players in the same service sector of the global pharma outsourcing industry. To help global pharma outsourcing companies and professional service providers as well as venture capital investors better ...
|
read more...
|
$395.00
|
|
Chinese Markets for HIV Treatment Drugs
11/1/2012 | published by: Asia Market Information & Development Company
... trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2001, 2006 and 2011) and long-term forecasts through 2016 and 2021 are presented. Major producers ...
|
read more...
|
$2,000.00
|
|
Chinese CRO Company Report - Beijing Genomic Institute (BGI)
11/1/2012 | published by: JZMed, Inc.
... as competent as those top tier players in the same service sector of the global pharma outsourcing industry. To help global pharma outsourcing companies and professional service providers as well as venture capital investors better ...
|
read more...
|
$395.00
|
|
Epidemiology: Rheumatoid Arthritis in China – Rapid urbanization presents favorable market potential
10/22/2012 | published by: Datamonitor
... of RA cases were among people living in rural areas. However, by 2021, 57% of RA cases will be urban. Introduction Gain insight into market potential, including a robust 10-year epidemiology forecast of RA prevalence ...
|
read more...
|
$5,700.00
|
|
Epidemiology: COPD in China – Aging, population growth, and increased survival will drive up prevalent cases over the next decade
10/2/2012 | published by: Datamonitor
... from approximately 42 million to nearly 56 million. This increase will be driven by demographic changes over the forecast period, including increased survival and a larger aged population. Features and benefits Gain insight to market ...
|
read more...
|
$3,800.00
|
|
Chinese Markets for Vaccines
10/1/2012 | published by: Asia Market Information & Development Company
... environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2001, 2006 and 2011) and long-term forecasts through 2016 and 2021 are presented. Major producers in China ...
|
read more...
|
$2,000.00
|
|
Chinese Markets for Cancer Treatment Drugs
10/1/2012 | published by: Asia Market Information & Development Company
... trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2001, 2006 and 2011) and long-term forecasts through 2016 and 2021 are presented. Major producers ...
|
read more...
|
$2,000.00
|
|
The New Trends of Drug R&D Outsourcing in China and India
9/1/2012 | published by: JZMed, Inc.
... in the areas related to drug R&D, which makes each country unique for certain types of drug R&D outsourcing activities. Although multinational drug companies now could have more choices than ever before, China and India ...
|
read more...
|
$6,885.00
|
|
The New Trends of Drug Development Outsourcing in China and India
9/1/2012 | published by: JZMed, Inc.
... in the areas related to drug R&D, which makes each country unique for certain types of outsourcing activities. Although multinational drug companies now could have more choices than ever before, China and India each actually ...
|
read more...
|
$4,285.00
|
|
Chinese Markets for Cardiovascular Drugs
9/1/2012 | published by: Asia Market Information & Development Company
... investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2001, 2006 and 2011) and long-term forecasts through 2016 and 2021 are presented. Major producers in ...
|
read more...
|
$2,000.00
|
|
Chinese Markets for Asthma Treatment Drugs
9/1/2012 | published by: Asia Market Information & Development Company
... trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2001, 2006 and 2011) and long-term forecasts through 2016 and 2021 are presented. Major producers ...
|
read more...
|
$2,000.00
|
|
Chinese Markets for Brain Cancer Treatment Drugs
9/1/2012 | published by: Asia Market Information & Development Company
... economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2001, 2006 and 2011) and long-term forecasts through 2016 and 2021 are presented. Major ...
|
read more...
|
$2,000.00
|
|
Chinese Markets for Bladder Cancer Treatment Drugs
8/1/2012 | published by: Asia Market Information & Development Company
... economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2001, 2006 and 2011) and long-term forecasts through 2016 and 2021 are presented. Major ...
|
read more...
|
$2,000.00
|
|
Chinese Markets for Liver Cancer Treatment Drugs
8/1/2012 | published by: Asia Market Information & Development Company
... economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2001, 2006 and 2011) and long-term forecasts through 2016 and 2021 are presented. Major ...
|
read more...
|
$2,000.00
|